In silico quantitative structure pharmacokinetic relationship modeling of quinolones: Apparent volume of distribution

Main Article Content

Yash Paul
Avinash S Dhake
Avinash S Dhake
Bhupinder Singh
Bhupinder Singh


The use of in silico approaches for successful prediction of pharmacokinetic properties of compounds during new drug discovery has been increasing exponentially. These in silico models, for the prognosis of absorption, distribution,
metabolism and excretion (ADME), are invariably based on the implementation of quantitative structure pharmacokinetic relationship (QSPR) techniques. The current study was conducted to investigate QSPR for apparent volume of distribution (Vd) in man among 24 Quinolone drugs employing an extrathermodynamic approach. It is vital to predict the Vd value of
various drug leads during drug discovery so that compounds with poor bioavailability can be eliminated and those with an acceptable metabolic stability can be identified. Analysis of several thousands of QSPR correlations developed in the present study revealed an extremely high degree of cross-validated coefficient (Q2) using the leave-one-out method (P < 0.001). Logarithmic transformation tends to improve the correlations marginally (R2 = 0.936) but the inverse transform resulted in a distinct improvement in the correlation (R2 = 0.994). Electronic and topological parameters were found to primarily ascribe the variation in Vd. Overall, the diffusional interactions seem to play a major role in attributing Vd rather than the
permeational ones.


Download data is not yet available.

Article Details

How to Cite
Paul, Y., Dhake, A. S., Dhake, A. S., Singh, B., & Singh, B. (2014). In silico quantitative structure pharmacokinetic relationship modeling of quinolones: Apparent volume of distribution. Asian Journal of Pharmaceutics (AJP), 3(3).


Waterbeemed VH, Gifford E. ADMET in silico modeling: Towards

prediction paradise? Nature Reviews. Drug Discov 2003;2:192-204.

Beresford AP, Segall M, Tabit MH. In-silico prediction of ADME properties:

Are we making progress? Curr Opin Drug Discov Develop 2004;7:36-42.

Shargel L, WU-Pong S, Andrew YU. Applied Biopharmaceutics and

Pharmacokinetics. 5th ed. McGraw Hill Companies Inc; 2005. p. 259,864-6.

Ghafourian T, Barzegar JM, Dastmalchi S, Khavari-Khoraseni T,

Kakimiha N, Nokhodchi A. QSPR models for the prediction of apparent

volume of distribution. Int J Pharm 2006;319:82-97.

Karlis V, Tsantili-Kakoulidou A, Macheras P. Quantitative structure

pharmaockinetic relationships for disposition parameters of

cephalosporins. Eur J Pharm Sci 2003;20:115-23.

Turner JV, Maddalena DJ, Cutler DJ, Agatonovic-Kustrin S. Multiple

pharmacokinetic parameter prediction for a series of cephalosporins.

J Pharm Sci 2003;92:552-9.

Saha RN, Raman N. Modeling of Biological Activity and Pharmacokinetics

of Cephalosporin Derivatives. Ind J Pharm Edu Res 2008;42:207-14.

Ng C. Xiao YD, Putnam W, Lum B, Tropsha A. Quantitative structure

pharmacokinetic parameters relationships (QSPKR) analysis

of antimicrobial agents in humans using simulated annealing

k-nearest- neighbor and partial least-square analysis methods. J Pharm

Sci 2004;93:2535-44.

Seydel JK. Structure pharmacokinetic relationship in drug design.

Amsterdam: Elsevier; 1982. p. 179.

Grover M, Singh B, Bakshi M, Singh S. Quantitative structure property

relationships in pharmaceutical research - Part-2. Pharm Sci Technol

Today 2000;3:50-7.

Singh B, Dhake AS, Sethi D, Paul Y. In silico ADME predictions

using Quantitative structure Pharmacokinetics Relationships Part-I:

Fundamental Aspects. Pharm Rev 2007;5:93-100.

Hooper DC, Wolfson JS. Quinolone Antimicrobial Agents. 2nd ed.

Washington: American Society for Microbiology; 1993. p. 195-223.

Mignot A, Guillaume M, Gohler K, Stahlberg HJ. Oral Bioavailability of

gatifloxacin in healthy volunteers under fasting and fed conditions.

Chemotherapy 2002;48:111-5.

The Merck Index: An Encyclopedia of Chemicals, Drugs and Biological.

th ed. USA: Merck Research Laboratories Division of Merck and Co

INC; 2006.

Bruton LL, Laza JS, Parker KL. Goodman Gilman’s: The Pharmacological

Basis of therapeutics. 11th ed. New York: McGraw-Hill Medical Publishing

Division; 2006. p. 940-50.

Watari N, Sugiyama Y, Kaneniwa N, Hiura M. Prediction of hepatic

first-pass metabolism and plasma levels following intravenous and

oral administration of barbiturates in the rabbit based on quantitative

structure-pharmacokinetic relationships. J Pharmacokinet Biopharm


Hirono S, Nakagome I, Hirono H, Matsushita Y, Yoshi F, Moriguchi I.

Non-congeneric structure-pharmacokinetic property correlation studies

using fuzzy adaptive least-square, oral bioavailability. Biol Pharm Bull


Blakey GE, Nestorov IA, Arundel PA, Aorons LJ, Rowland M. Quantitative

structure-pharmacokinetics relationships (QSPR), 1. Development of

a whole-body physiologically based model to characterize changes in

pharmacokinetics across a homologous series of barbiturates in the

rat. J Pharmacokinet Biopharm 1997;25:277.

Houglum J, Harrelson G, Leaver-Dunn D. Principles of Pharmacology

for Athletic Trainers. USA: Slack Incorporated; 2005. p. 19-82.